Clinical Trial Update: A Research Study, Looking at How Ryzodeg® (Insulin Degludec/Insulin Aspart) Works in People With Type 2 Diabetes in Local Clinical Practice

View source ↗

Summary

A completed clinical trial evaluating how Ryzodeg (insulin degludec/insulin aspart) works in people with type 2 diabetes in local clinical practice.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Ryzodeg (insulin degludec/insulin aspart)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes Mellitus, Type 2 | Status: COMPLETED